DSGN EFFECT: Shelf registration

Filed with the SEC on · accession 9999999995-26-003535

DSGN filed a EFFECT (effect) with the SEC on Nov 12, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.8% by the first close after the filing.

Summary of the filing

The SEC declared effective Design Therapeutics' Form S-3 shelf registration statement (File No. 333-299827) on November 12, 2026, allowing the company to offer and sell securities from time to time.

Key details

RegistrantDesign Therapeutics, Inc.

How DSGN stock reacted

Close before

$10.77

Nov 11, 2026

First close after

-1.76%

$10.58

5 trading days

—

Since filing

-7.89%

$9.92

✦ Ask GOAX AI about this filing — what it means for DSGN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DSGN?

Click here

Frequently asked questions

What did DSGN file with the SEC on Nov 12, 2026?

DSGN filed a EFFECT (Shelf registration). The SEC declared effective Design Therapeutics' Form S-3 shelf registration statement (File No. 333-299827) on November 12, 2026, allowing the company to offer and sell securities from time to time.

What does a shelf registration mean for DSGN stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a EFFECT?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).

How did DSGN stock react to this filing?

DSGN closed at $10.77 before the filing and $10.58 on Nov 12, 2026 (-1.76%).

Other DSGN SEC filings

Get alerts when DSGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days